Search

2 result(s) for 'author#"Aaron M. Goodman"' within BMC

1. MHC-I genotype and tumor mutational burden predict response to immunotherapy

   Immune checkpoint blockade (ICB) with antibodies inhibiting cytotoxic T lymphocyte-associated protein-4 (CTLA-4) and programmed cell death protein-1 (PD-1) (or its ligand (PD-L1)) can stimulate immune response...

   Authors: Aaron M. Goodman, Andrea Castro, Rachel Marty Pyke, Ryosuke Okamura, Shumei Kato, Paul Riviere, Garrett Frampton, Ethan Sokol, Xinlian Zhang, Edward D. Ball, Hannah Carter and Razelle Kurzrock

   Citation: Genome Medicine 2020 12:45

   Content type: Research

   Published on: 19 May 2020

   • View Full Text
   • View PDF

2. Rosai-Dorfman-Destombes (RDD) disease presenting as palindromic rheumatism

   Rosai-Dorfman-Destombes (RDD) disease, is a rare proliferative and inflammatory disorder of non-Langerhans cell histiocytes.

   Authors: Amin Haghighat Jahromi, Aaron M. Goodman and Carl K. Hoh

   Citation: BMC Medical Imaging 2021 21:72

   Content type: Case report

   Published on: 15 April 2021

   • View Full Text
   • View PDF